How to Use Red Light for Your Thyroid: The Exact Protocol I’ve Used on 1,000+ Patients

If you have a thyroid problem, red light therapy might be one of the best treatments available to you.

Why? Because it stacks on top of all other thyroid treatments, including medications.

The problem is not that it doesn’t work; it’s that most protocols (and devices) weren’t made for thyroid patients.

Which is why I created this one. It has been used on over 1,000+ thyroid patients to date and actually works:

The Thyroid Red Light Protocol

Initial treatment phase

• Wavelengths: 630, 660, 830, 850nm
• Distance: flush to the skin
• Irradiance: 50 mW/cm²
• Duration: 10-20 minutes per session
• Frequency: 3-5x per week
• Placement: thyroid (front of neck)
• Total length of use: 12 weeks

This is the protocol I recommend for thyroid patients just starting red light therapy.

The goal during this phase is to produce a measurable change in symptoms, antibodies, and thyroid function.

To do that, you need consistent treatment over a 12-week window because that’s how long it takes for thyroid tissue to adapt at the cellular level and for hair, energy, and lab work to follow.

The clinical research this protocol is built on shows that the same wavelength and irradiance settings used 2-3x per week produced significant changes in TSH, TPO antibodies, and levothyroxine requirements after 12 weeks of treatment.^[1]

Maintenance phase

• Same parameters as the initial phase
• Frequency: 3x per week
• Duration: 10-20 minutes per session

Once you’ve completed the initial 12-week phase, the goal shifts from producing change to maintaining the gains you’ve made.

The reason you don’t stop is because the changes red light produces are dose-dependent and tissue-specific.

If you stop using it, your thyroid doesn’t suddenly fall apart, but mitochondrial output and circulation slowly start to drift back toward baseline.

Maintenance keeps the gains locked in without overdoing it. Three sessions per week is the minimum effective dose long-term.

The Protocol Explained

Here’s why each variable is set where it is.

#1 Why these wavelengths

Red light (630-660nm) and near-infrared (830-850nm) penetrate to different tissue depths.^[7]

Red light penetrates roughly 1-2mm and is absorbed primarily by skin, capillaries, and surface tissue.

Near-infrared penetrates 2-5mm and reaches the deeper tissue where your thyroid sits.

You need both. If you only use red light, you’re not reaching the thyroid gland itself. If you only use near-infrared, you miss the skin and surface circulation effects.

Most cheap devices use only one wavelength. The protocol requires all four.

#2 Why flush to the skin

Distance affects irradiance, and irradiance is what does the work.

Every inch you move the device away from your skin, the energy delivered to the tissue drops off significantly.

By the time a panel is sitting 6 inches away, you’ve lost most of the irradiance that would have made the session therapeutic.

A device that delivers 50 mW/cm² at skin contact might deliver only 10-15 mW/cm² at 6 inches. That’s the difference between a protocol that works and one that doesn’t.

Flush contact is the only way to guarantee you’re getting the dose you need.

#3 Why 10-20 minutes

Red light follows a biphasic dose response curve.^[6]

That means there’s a sweet spot. Too little, and you don’t trigger the cellular response. Too much, and you overshoot and the benefits start to reverse.

For thyroid tissue at 50 mW/cm² irradiance, that sweet spot is 10-20 minutes.

Longer sessions don’t give you more benefit and may actually reduce the response.

This is one of the biggest mistakes I see thyroid patients make. They assume more is better and run 30-45 minute sessions, which puts them on the wrong side of the curve.

#4 Why 3-5x weekly

The thyroid responds to consistent stimulation, not heroic single sessions.

Three to five sessions per week gives the tissue enough exposure to produce change while allowing time for the cellular response to play out between treatments.

Daily use is fine if you can manage it.

Some patients with more advanced Hashimoto’s or sluggish thyroid function do better on daily treatment during the initial 12 weeks. The biphasic curve still applies, so don’t extend session length to compensate.

#5 Why thyroid gland directly

The thyroid sits roughly 2-4cm below the skin in the front of the neck.

That’s well within the penetration depth of 830-850nm near-infrared light when the device is flush to the skin.

Treating the thyroid directly gives you the highest concentration of photons reaching the tissue you actually want to affect. Treating areas like the wrist or general body doesn’t reach the thyroid.

This is why panels at a distance don’t work for thyroid protocols. The combination of distance plus non-targeted placement loses too much of the dose to be effective.

#6 Why 12 weeks minimum

Thyroid tissue, hair, and labs all operate on a slower timeline than skin or muscle.

Hair has a growth cycle that takes roughly 8-12 weeks to show measurable changes. Thyroid antibody levels lag symptoms by 6-12 weeks. Lab work like TSH and free T4 won’t fully reflect tissue-level changes until you’ve had 12+ weeks of consistent treatment.

The clinical research that backs this protocol uses 6-9 month treatment windows because that’s where the strongest signal shows up.^[1]

Twelve weeks is the floor.

If you stop at week 6 because you’re not seeing results yet, you stopped before the protocol had a chance to work.

Outcomes From Real Thyroid Patients Using This Protocol

Here’s what we’ve seen across patients using this exact protocol.

88.8% Overall Satisfaction

This is unusually high for any thyroid intervention.

Most thyroid supplements and devices see 60-70% satisfaction at best. The 88.8% figure reflects the specificity of the protocol matching the specificity of the device.

When the wavelengths, irradiance, contact, and placement all match what the research shows works for thyroid tissue, the response rate goes up.

62% Reported Thyroid Improvement

This is the core outcome.

Six in ten patients reported a specific thyroid-related improvement: reduced TSH, increased free T4, lower antibodies, less neck pressure, or improved energy traceable to thyroid function.

This matches what the Höfling randomized controlled trial showed in 2013, where the treated group saw significant reductions in levothyroxine requirements and antibody levels compared to placebo.^[1]

For more detail on the antibody side specifically, see TPO antibodies and what high levels mean.

36.6% Reported More Energy

Energy is the fastest responding symptom because it’s the most direct readout of mitochondrial ATP production.^[8]

Near-infrared light at 830-850nm has been shown to increase mitochondrial output through direct effects on cytochrome c oxidase, which is the enzyme that powers the final step of ATP production.^[5]

When mitochondrial function improves, energy comes back before lab values change. If you’re going to feel something first, this is usually it.

You can read more about how thyroid function and metabolism are connected.

26.8% Reported Lab or Physical Changes

This is the slowest but most validating outcome.

Lab markers like TSH and free T4 lag symptoms by 6-12 weeks. Physical changes like neck swelling reduction, weight changes, and improved hair need sustained treatment to show up.

The Höfling group also documented improved thyroid arterial flow on Doppler ultrasound in patients using this same protocol, which is a structural tissue change.^[4]

The lower percentage here isn’t a failure of the protocol. It reflects the time it takes for these markers to update, and many patients don’t recheck labs until they’re already feeling better.

A note on non-responders

Roughly 11% of patients reported no measurable benefit.

This is honest reporting. Red light isn’t a fix for every thyroid problem, and the patients who don’t respond usually fall into one of three categories: they stopped before 12 weeks, they were using an underpowered device, or they had a thyroid pattern (severe Graves’, late-stage hypothyroidism, post-thyroidectomy) where the underlying tissue isn’t responsive to photobiomodulation.

Response order pattern

There’s a typical order in which these outcomes show up.

Energy first (week 2-6). Thyroid symptoms next (week 6-10). Lab and physical changes last (week 8-12+).

Hair changes can show up at any point in the second half of the protocol depending on where you are in your hair growth cycle. For Hashimoto’s-related hair changes specifically, the types and causes of Hashimoto’s hair loss tend to respond in the same window.

If you don’t see energy changes by week 4-6, your device or your protocol setup likely needs adjustment.

How Long Until You See Results

Here’s what to expect at each stage of the 12-week initial phase.

How To Tell If It's Really Your Thyroid: Get My Hypothyroid Symptoms Checklist

Get the PDF. Check off your symptoms. Find out in 60 seconds if it's your thyroid (or something else).

First Name

Email address

No spam. Unsubscribe anytime.

Leave this field empty if you're human:

Week 2: Most patients don’t feel much yet. Sleep may start to feel slightly deeper or more restorative. This is mitochondrial activity ramping up.

Week 4: Energy improvements start showing up for the patients who will respond on this front. If you’re going to feel a clear energy lift, you’ll usually feel it by now.

Week 8: Thyroid symptom improvements become more obvious. Less brain fog, less cold intolerance, better mood. Hair may start to feel thicker at the root.

Week 12: Lab changes begin to show up. This is the right time to recheck TSH, free T4, free T3, and antibodies if you started this protocol with a goal of lowering medication. Physical changes (neck swelling, weight, hair density) are also visible by this point.

If you’ve followed the protocol consistently for 12 weeks and you don’t see any of the above, the issue is almost always the device.

Common Mistakes I See Patients Make

These are the patterns that cause this protocol to fail.

#1 Getting a panel instead of a flush-contact device

Panels at distance lose too much irradiance.

By the time the light reaches your thyroid, you’re at 10-20% of the dose you should be getting.

If you’re going to invest in a device, get one that delivers full irradiance at skin contact.

#2 Getting a device that’s underpowered

Some red light therapy devices on the market deliver 5-15 mW/cm² at the surface, not 50.

That’s a fraction of the clinically validated dose. Even with perfect contact and timing, you won’t trigger the cellular changes the protocol requires.

#3 Getting a device with the wrong wavelengths

A lot of cheap devices use a single wavelength, usually 660nm or 850nm.

You need both red and near-infrared. Red for the surface (skin, circulation), near-infrared for the depth (thyroid tissue itself).

#4 Not giving the protocol enough time

Twelve weeks is the floor, not the goal.

If you stop at week 4 or 6 because you’re not seeing fast enough changes, you stopped before the tissue had a chance to respond.

#5 Inconsistent use

The protocol depends on consistent stimulation.

Doing it 5 times one week and then once the next doesn’t work. Pick a frequency you can actually stick with and run it for the full 12 weeks.

Where to Start

The protocol works when the device matches it.

You need a device that delivers 50 mW/cm² at skin contact, has all four wavelengths (630, 660, 830, 850nm), is designed for direct application to the thyroid, and isn’t a panel sitting on a stand.

The Thyro Light is the device I built for exactly this protocol. It hits the irradiance spec, uses the four-wavelength combination, and is designed to sit flush against the front of the neck. For more on choosing a device, see the best red light for thyroid.

Red light is also safe to combine with thyroid medication of any kind, and many patients on this protocol have been able to lower their medication needs in coordination with their doctor after the initial 12 weeks.^[2] If you’re working on lowering antibodies and reducing your dependence on levothyroxine, this protocol pairs well with a broader Hashimoto’s natural treatment approach.

Start the protocol, run it for 12 weeks, recheck your labs, and adjust from there.

References

1. Höfling, D.B., et al. (2013). Low-level laser in the treatment of patients with hypothyroidism induced by chronic autoimmune thyroiditis: a randomized, placebo-controlled clinical trial. Lasers in Medical Science, 28(3), 743-753. [https://pubmed.ncbi.nlm.nih.gov/22718472/]
2. Höfling, D.B., et al. (2010). Low-level laser therapy in chronic autoimmune thyroiditis: a pilot study. Lasers in Surgery and Medicine, 42(6), 589-596. [https://pubmed.ncbi.nlm.nih.gov/20662037/]
3. Höfling, D.B., et al. (2018). Safety and Efficacy of Low-Level Laser Therapy in Autoimmune Thyroiditis: Long-Term Follow-Up Study. International Journal of Endocrinology, 2018, 8387530. [https://pubmed.ncbi.nlm.nih.gov/30532779/]
4. Höfling, D.B., et al. (2012). Assessment of the effects of low-level laser therapy on the thyroid vascularization of patients with autoimmune hypothyroidism by color Doppler ultrasound. ISRN Endocrinology, 2012, 126720. [https://pubmed.ncbi.nlm.nih.gov/23316383/]
5. Chung, H., et al. (2012). The nuts and bolts of low-level laser (light) therapy. Annals of Biomedical Engineering, 40(2), 516-533. [https://pubmed.ncbi.nlm.nih.gov/22045511/]
6. Huang, Y.Y., et al. (2011). Biphasic dose response in low level light therapy – an update. Dose-Response, 9(4), 602-618. [https://pubmed.ncbi.nlm.nih.gov/22461763/]
7. Salehpour, F., et al. (2019). Penetration Profiles of Visible and Near-Infrared Lasers and Light-Emitting Diode Light Through the Head Tissues in Animal and Human Species: A Review of Literature. Photobiomodulation, Photomedicine, and Laser Surgery, 37(10), 581-595. [https://pubmed.ncbi.nlm.nih.gov/31553265/]
8. Ferraresi, C., et al. (2016). Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness: Case-control Study with a Pair of Identical Twins. American Journal of Physical Medicine & Rehabilitation, 95(10), 746-757. [https://pubmed.ncbi.nlm.nih.gov/27088469/]